Viroptic en es it fr

Viroptic Brand names, Viroptic Analogs

Viroptic Brand Names Mixture

  • No information avaliable

Viroptic Chemical_Formula


Viroptic RX_link

Viroptic fda sheet

Viroptic FDA

Viroptic msds (material safety sheet)

Viroptic Synthesis Reference

No information avaliable

Viroptic Molecular Weight

718.794 g/mol

Viroptic Melting Point

No information avaliable

Viroptic H2O Solubility

No information avaliable

Viroptic State


Viroptic LogP


Viroptic Dosage Forms

Powder for solution to be mixed for injection (2mg verteporfin/mL reconstituted verteporfin)

Viroptic Indication

For the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis.

Viroptic Pharmacology

Verteporfin, otherwise known as benzoporphyrin derivative, is a medication used in conjunction with laser treatment to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. Verteporfin accumulates in these abnormal blood vessels and, when stimulated by nonthermal red light with a wavelength of 693 nm in the presence of oxygen, produces highly reactive short-lived singlet oxygen and other reactive oxygen radicals, resulting in local damage to the endothelium and blockage of the vessels.

Viroptic Absorption

No information avaliable

Viroptic side effects and Toxicity

Overdose of drug and/or light in the treated eye may result in nonperfusion of normal retinal vessels with the possibility of severe decrease in vision that could be permanent. An overdose of drug will also result in the prolongation of the period during which the patient remains photosensitive to bright light.

Viroptic Patient Information

Viroptic Organisms Affected

Humans and other mammals